Results with nicergoline in 30 subjects with cerebral arteriosclerosis

Categoría Estudio primario
RevistaGazzetta Medica Italiana
Año 1974
Cargando información sobre las referencias
A three to four wk clinical trial of nicergoline in 30 arteriosclerotic subjects aged 49 to 83 yr is reported. Two 1 mg ampoules/day for five days were followed by 20 drops (= 5 mg) three times a day over the remainder of the period. Somatic and neuropsychological symptoms and laboratory data were assessed. The results were classed as good in 22 cases, fair in 5 and nil in 3. Improvement was statistically significant for all symptoms, save visual disturbances. No side effects were noted.
Epistemonikos ID: d63d01bfde13c39c896c536265cf0b63021104dd
First added on: Feb 03, 2025